KRP549
V型和免疫球蛋白结构域含有蛋白2, V-set and immunoglobulin domain-containing protein 2 , Cortical thymocyte-like protein, CT-like protein, CTH, CTXL, UNQ2770/PRO7154, V-set and immunoglobulin domain-containing protein 2
| Catalog Number | KRP549 |
| Alias | V型和免疫球蛋白结构域含有蛋白2, V-set and immunoglobulin domain-containing protein 2 , Cortical thymocyte-like protein, CT-like protein, CTH, CTXL, UNQ2770/PRO7154, V-set and immunoglobulin domain-containing protein 2 |
| Size | 20ug, 50ug, 100ug, 200ug, 1mg |
| Product Description | Human VSIG2(Val24-Ala243) |
| Molecular Name | VSIG2 |
| Product Introduction | V型和免疫球蛋白结构域含有蛋白2参与细胞信号传导和免疫反应。。 |
| Molecular Weight | 54-65 kDa |
| Expression System | HEK293F Cells |
| Species | Human |
| Concentration | 联系销售经理获得最新批次的浓度 |
| Purity | ≥95% |
| SDS-PAGE | |
| Purification | Affinity Purification |
| Uniprot ID | Q96IQ7 |
| Storage Condition | Store the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles. |
| Formulation | Supplied in PBS |
| Shipping Condition | This product is shipped on ice packs or dry ice. |
| Endotoxin | < 0.1 EU per ug |
| Biological Activity | Measured by its ability to inhibit anti-CD3 antibody induced IFNgamma secretion by human peripheral blood mononuclear cells (PBMC). The ED50 for this effect is 5- 25 μg/mL. |
| Product Declaration | 该产品仅供科研使用，不可直接用于人体或注射。 |
销售微信
官方公众号
0
